Stay updated with breaking news from Johnson Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a strategic shift, with around $30 billion invested in MedTech over 18 months.
Johnson & Johnson JNJ agreed on Friday to acquire Shockwave Medical Inc SWAV for $335 per share in cash, corresponding to an enterprise value of approximately…
Johnson & Johnson (NYSE: JNJ) announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion.
Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in...
Johnson & Johnson to acquire Shockwave Medical for $335.00/share in cash, bolstering its cardiovascular intervention portfolio. The acquisition, expected to close by mid-2024, signifies Johnson & Johnson's strategic focus on innovation and market expansion.